drugset
Drugs / Inactivated Influenza Vaccine (IIV4)
last change Dec 2023 re-read 3 minutes ago

Inactivated Influenza Vaccine (IIV4)

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · National Institutes of Health (NIH) · Stanford University

Trials 1

today NCT03898986 · Ph 1
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT03898986 Oct 2019 → Dec 2023 influenza Stanford University Completed No outcome recorded
Comparator or background therapy1 trial
Phase 3 NCT02290509 Comparator Oct 2014 → May 2015 influenza Protein Sciences Corporation Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Inactivated Influenza Vaccine (IIV4) ClinicalTrials.gov intervention name — accepted as the source's own label NCT03898986 ↗
1

NCT02290509 ↗
Modality Vaccine “a standard-dose, egg-grown, quadrivalent-inactivated influenza vaccine (IIV4)” PMID 28968871 ↗ Dec 2017
Route Intramuscular “Intramuscular injection of vaccine contains 4 x 15µg (60µg total)” NCT02290509 ↗